Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Abstract: Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Revisão |
| שפה: | אנגלית |
| יצא לאור: |
2016
|
| גישה מקוונת: | https://doi.org/10.2147/bctt.s114659 https://www.dovepress.com/getfile.php?fileID=32807 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|